'The future of getting Medicare to negotiate drug prices under President Biden could either become part of his legacy or be rolled back by the incoming Congress.'
'Trump has remained relatively mum about the drug pricing provisions, and its future appears murkier now that Republicans will control both the House and Senate.'
'More than a dozen lawsuits targeting the program are also still playing out in the courts, which intensifies the uncertainty surrounding its implementation.'
Collection
[
|
...
]